Immunohistological investigation of mononuclear cell infiltrates in meningiomas

I Becker1, W Roggendorf

  • 1Institut für Hirnforschung, Universität Tübingen, Federal Republic of Germany.

Acta Neuropathologica
|January 1, 1989
PubMed

Insights

Inflammatory cell infiltration is more pronounced in malignant meningiomas compared to benign types. Tumor defense mechanisms in meningiomas are primarily mediated by T-cell immunity.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Pathology

Background:

  • Meningiomas are primary tumors of the central nervous system, with varying grades of malignancy.
  • The role of inflammatory cells and their subtypes in meningioma progression is not fully understood.

Purpose of the Study:

  • To investigate the density and subpopulations of inflammatory cells in different meningioma subtypes.
  • To determine the relationship between inflammatory infiltration and meningioma malignancy.

Main Methods:

  • Immunohistochemical analysis of 42 meningioma samples.
  • Cell counting to evaluate inflammatory cell density and infiltrate composition.

Main Results:

  • Benign meningiomas (meningothelial, fibroblastic) showed 3% mononuclear cells, primarily perivascular lymphocytes.
  • Malignant subtypes with atypia and recurrent tumors had increased inflammatory cells (up to 9%).
  • Anaplastic meningiomas exhibited marked infiltration (average 13.5%), with intraparenchymal clusters and perivascular cuffing.

Conclusions:

  • Inflammatory infiltration is significantly more frequent and denser in malignant meningiomas than in benign ones.
  • T-cell mediated immunity appears to be a key component of the tumor defense mechanisms in meningiomas.

Related Concept Videos